Canadian Biotech To Apply Biocompatible Coating To Drug-Eluting Stents
This article was originally published in The Gray Sheet
Executive Summary
Biocompatible coating developer MIV Therapeutics (MIVT) says it is in talks with drug manufacturers to discover a compound exhibiting "paclitaxel-like" traits for integration with the firm's emerging stent line